DPHARMA

1.290

+0.02 (+1.6%)

OTHERS ACCEPTANCE OF TENDER OFFER (HEREINAFTER REFERRED TO AS THE "LETTER OF AWARD" OR "LOA") FOR THE SUPPLY OF INSULIN INJECTION (HEREINAFTER REFERRED TO AS THE "PRODUCT") BY DUOPHARMA (M) SENDIRIAN BERHAD (A WHOLLY-OWNED SUBSIDIARY OF DUOPHARMA BIOTECH BERHAD) TO THE MINISTRY OF HEALTH'S FACILITIES

DUOPHARMA BIOTECH BERHAD

Type Announcement
Subject OTHERS
Description
ACCEPTANCE OF TENDER OFFER (HEREINAFTER REFERRED TO AS THE "LETTER OF AWARD" OR "LOA")
FOR THE SUPPLY OF INSULIN INJECTION (HEREINAFTER REFERRED TO AS THE "PRODUCT") BY DUOPHARMA (M) SENDIRIAN BERHAD (A WHOLLY-OWNED SUBSIDIARY OF DUOPHARMA BIOTECH BERHAD) TO THE MINISTRY OF HEALTH'S FACILITIES

The Board of Directors of Duopharma Biotech Berhad (hereinafter referred to as “Duopharma Biotech” or the “Company”) wishes to announce that the Government has accepted the tender offer from Duopharma (M) Sendirian Berhad (hereinafter referred to as “DMSB”) (a wholly-owned subsidiary of Duopharma Biotech) to supply the Product to the Ministry of Health’s facilities (hereinafter referred to as the “Letter of Award” or “LOA”) upon the terms and conditions set out in the Letter of Award. DMSB has acknowledged acceptance of the LOA and submitted the same to the Ministry of Health. 

 

For full details of the announcement, please refer to the attached file.


This announcement is dated 16 February 2026.




Please refer attachment below.



Announcement Info

Company Name DUOPHARMA BIOTECH BERHAD
Stock Name DPHARMA
Date Announced 16 Feb 2026
Category General Announcement for PLC
Reference Number GA1-16022026-00061